[PDF][PDF] Immunity to enteric viruses

A Lockhart, D Mucida, R Parsa - Immunity, 2022 - cell.com
Pathogenic enteric viruses are a major cause of morbidity and mortality, particularly among
children in developing countries. The host response to enteric viruses occurs primarily within …

[HTML][HTML] Mucosal immunity to poliovirus

RI Connor, EB Brickley, WF Wieland-Alter… - Mucosal …, 2022 - Elsevier
A cornerstone of the global initiative to eradicate polio is the widespread use of live and
inactivated poliovirus vaccines in extensive public health campaigns designed to prevent …

[HTML][HTML] Distinct features and functions of systemic and mucosal humoral immunity among SARS-CoV-2 convalescent individuals

SE Butler, AR Crowley, H Natarajan, S Xu… - Frontiers in …, 2021 - frontiersin.org
Understanding humoral immune responses to SARS-CoV-2 infection will play a critical role
in the development of vaccines and antibody-based interventions. We report systemic and …

Longitudinal systemic and mucosal immune responses to SARS-CoV-2 infection

PF Wright, AC Prevost-Reilly… - The Journal of …, 2022 - academic.oup.com
Background A longitudinal study was performed to determine the breadth, kinetics, and
correlations of systemic and mucosal antibody responses to severe acute respiratory …

[HTML][HTML] Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine

T Zhao, J Li, Y Fu, H Ye, X Liu, G Li, X Yang, J Yang - npj Vaccines, 2020 - nature.com
The impact of intestinal microbiota on mucosal antibody response to the polio vaccine is
poorly understood. We examined changes in vaccine-induced intestinal mucosal immunity …

[HTML][HTML] Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well …

JW Crothers, ER Colgate, KJ Cowan, DM Dickson… - Vaccine, 2022 - Elsevier
Eradication of poliomyelitis globally is constrained by fecal shedding of live polioviruses,
both wild-type and vaccine-derived strains, into the environment. Although inactivated polio …

[HTML][HTML] Neonatal immunization: rationale, current state, and future prospects

E Whittaker, D Goldblatt, P McIntyre, O Levy - Frontiers in immunology, 2018 - frontiersin.org
Infections take their greatest toll in early life necessitating robust approaches to protect the
very young. Here, we review the rationale, current state, and future research directions for …

[HTML][HTML] Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus …

X Tang, Y Xiao, X Deng, Y Zhou, H Chen… - The Lancet Regional …, 2023 - thelancet.com
Background Sabin inactivated and bivalent oral poliovirus vaccine (sIPV, bOPV) were
commonly used in China since 2016. We conducted an open-label, randomised, controlled …

[HTML][HTML] LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice

E Valli, AJ Harriett, MK Nowakowska, RL Baudier… - Scientific Reports, 2019 - nature.com
Enterotoxin-based adjuvants including cholera toxin and heat-labile toxin (LT) are powerful
manipulators of mucosal immunity; however, past clinical trials identified unacceptable …

Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus

J Quarleri - Geroscience, 2023 - Springer
For more than 20 years, the World Health Organization Western Pacific Region (WPR) has
been polio-free. However, two current challenges are still polio-related. First, around half of …